Fasting plasma glucose
Fasting plasma glucose has been studied in 2 papers since 2025: 2 observational studies in people; 2 in the past year. The newest paper, Jul 3, 2026: “Unhealthy fat distribution as a sex-specific predictor of declining hippocampus insulin sensitivity”.
2 papers study it2 findingsUpdated
See all 2 papers on fasting plasma glucose
At a glance
The findings reach people, from one lab or study. 2 independent labs in 2 countries.
“Hazard ratios (HRs) of incident CRMM associated with each 1-standard deviation (SD) increase in FPG, 2hPG, insulin (natural log), and HOMA-IR (natural log) were 1.48 (95 % CI: 1.34-1.64)”
None of its findings points the other way.
- 2 independent labs in 2 countries
- Funders: Bundesministerium für Forschung, Technologie und Raumfahrt and 5 more
- Humans2
What is fasting plasma glucose linked with?
2Studies link fasting plasma glucose with 2 measures: hippocampal insulin response and cardio-renal-metabolic multimorbidity.
Hippocampal insulin response
downin humans1
1 study
Hippocampal insulin response
downin humans1
Fasting plasma glucose predicts hippocampal insulin response in humans (independently of sex, with increasing age) (estimate 0.533, p=0.016).
“Fasting plasma glucose levels predicted lower hippocampal insulin response with age independently of sex (estimate 0.533, p=0.016).”
Humansindependently of sex, with increasing agehippocampus
Unhealthy fat distribution as a sex-specific predictor of declining hippocampus insulin sensitivity
Diabetologia
Cardio-renal-metabolic multimorbidity
upin humans1HR 1.48
1 study
Cardio-renal-metabolic multimorbidity
upin humans1HR 1.48
Fasting plasma glucose is linked with a higher risk of cardio-renal-metabolic multimorbidity in humans (per 1-standard deviation increase) (HR 1.48 (95% CI 1.34-1.64) per 1-SD increase).
“Hazard ratios (HRs) of incident CRMM associated with each 1-standard deviation (SD) increase in FPG, 2hPG, insulin (natural log), and HOMA-IR (natural log) were 1.48 (95 % CI: 1.34-1.64)”
Humansper 1-standard deviation increasemedian follow-up of 15.3 years
American journal of preventive cardiology